ArticleScientific reports2025
Synergistic effects of heterojunction graphene oxide nanocomposites in photocatalytic degradation of norfloxacin and hydrogen generation via water splitting.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Norfloxacin (NOFX), a common fluoroquinolone antibiotic, has recently raised significant concerns due to its adverse effects on both humans and the aquatic environment. In this work, a CuS-ZnS p-n heterojunction was introduced with graphene oxide (GO) sheets using a simple solvothermal technique. ZnS nanoparticles (NPs) have a hexagonal crystal phase and a cubic morphology. In contrast, CuS NPs have a cylindrical shape, and GO has wrinkled flakes. Under visible light, the ZnS/CuS/GO nanocomposite's exceptional hydrogen generation rate and remarkable photodegradation properties were caused by its variable bandgap. It was discovered that the optimal conditions for NOFX drug's breakdown were 50 mg of catalyst and 10 ppm of drug concentration at 30 °C, pH 10, and 300 W Xenon light. The efficiency of drug degradation rose from around ~ 19% to about ~ 86% which is consistent with first-order reaction kinetics. Nanocomposite has outstanding structural stability and can be recycled 5 times, with a noticeable decrease in photocatalytic effectiveness from ~ 86% to ~ 80%. Additionally, to assess the hydrogen production efficiency of the synthesised samples in the presence of sodium thiosulphate, which served as the sacrificial agent, photocatalytic water splitting tests were conducted. Hydrogen generation efficiency was found to be minimum for ZnS (276 µmol/g/h) in 120 min, which was enhanced to 452 µmol/g/h for ZnS/CuS/GO nanocomposite.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.